Daiichi Must Follow Turalio Patients For 10 Years To Assess Liver Safety

Cancer-cells-pink-color_1200x675
The Turalio hepatotoxicity 10-year follow-up and final study report are due in 2036. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approvals

More from Product Reviews